Clinical Trial Update: Individual Patient Compassionate Use of Crenolanib

View source ↗

Summary

Clinical trial update indicating that crenolanib is available for individual patient compassionate use in cancers with FLT3-ITD/FLT3-TKD mutations and PDGFRA al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Gastrointestinal Stromal Tumor

Drugs mentioned

• Crenolanib (Crenolanib)

Snippet

Sponsor: Arog Pharmaceuticals, Inc. | Conditions: FLT3-ITD Mutation, FLT3/TKD Mutation | Status: AVAILABLE